Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients.

Hdl Handle:
http://hdl.handle.net/10147/230454
Title:
Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients.
Authors:
Gabardi, Steven; Catella, Jennifer; Martin, Spencer T; Perrone, Ronald; Chandraker, Anil; Magee, Colm C; McDevitt-Potter, Lisa M
Affiliation:
Abdominal Organ Transplant Clinical Specialist–Departments of Transplant Surgery and Pharmacy Services, and the Renal Division, Brigham and Women's Hospital, Boston, MA, USA. sgabardi@partners.org
Citation:
Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients. 2011, 45 (9):e48 Ann Pharmacother
Journal:
The Annals of pharmacotherapy
Issue Date:
Sep-2011
URI:
http://hdl.handle.net/10147/230454
DOI:
10.1345/aph.1Q019
PubMed ID:
21811001
Abstract:
To report what we believe to be the first 2 cases of long-term (>24 months) intermittent intravenous interleukin-2 receptor antibody (IL-2RA) therapy for maintenance immunosuppression following renal transplantation.
Item Type:
Article
Language:
en
MeSH:
Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Female; Follow-Up Studies; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Receptors, Interleukin-2; Recombinant Fusion Proteins; Time Factors
ISSN:
1542-6270

Full metadata record

DC FieldValue Language
dc.contributor.authorGabardi, Stevenen_GB
dc.contributor.authorCatella, Jenniferen_GB
dc.contributor.authorMartin, Spencer Ten_GB
dc.contributor.authorPerrone, Ronalden_GB
dc.contributor.authorChandraker, Anilen_GB
dc.contributor.authorMagee, Colm Cen_GB
dc.contributor.authorMcDevitt-Potter, Lisa Men_GB
dc.date.accessioned2012-06-25T09:36:09Z-
dc.date.available2012-06-25T09:36:09Z-
dc.date.issued2011-09-
dc.identifier.citationMaintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients. 2011, 45 (9):e48 Ann Pharmacotheren_GB
dc.identifier.issn1542-6270-
dc.identifier.pmid21811001-
dc.identifier.doi10.1345/aph.1Q019-
dc.identifier.urihttp://hdl.handle.net/10147/230454-
dc.description.abstractTo report what we believe to be the first 2 cases of long-term (>24 months) intermittent intravenous interleukin-2 receptor antibody (IL-2RA) therapy for maintenance immunosuppression following renal transplantation.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to The Annals of pharmacotherapyen_GB
dc.subject.meshAntibodies, Monoclonal-
dc.subject.meshAntibodies, Monoclonal, Humanized-
dc.subject.meshFemale-
dc.subject.meshFollow-Up Studies-
dc.subject.meshGraft Rejection-
dc.subject.meshHumans-
dc.subject.meshImmunoglobulin G-
dc.subject.meshImmunosuppressive Agents-
dc.subject.meshKidney Transplantation-
dc.subject.meshMiddle Aged-
dc.subject.meshReceptors, Interleukin-2-
dc.subject.meshRecombinant Fusion Proteins-
dc.subject.meshTime Factors-
dc.titleMaintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients.en_GB
dc.typeArticleen
dc.contributor.departmentAbdominal Organ Transplant Clinical Specialist–Departments of Transplant Surgery and Pharmacy Services, and the Renal Division, Brigham and Women's Hospital, Boston, MA, USA. sgabardi@partners.orgen_GB
dc.identifier.journalThe Annals of pharmacotherapyen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.